Results 91 to 100 of about 11,672,769 (309)

Editorial: Women in Soil Science

open access: yesSpanish Journal of Soil Science, 2022
Michele Louise Francis   +2 more
doaj   +1 more source

Special Libraries, January 1917 [PDF]

open access: yes, 1917
Volume 8, Issue 1https://scholarworks.sjsu.edu/sla_sl_1917/1000/thumbnail ...
Special Libraries Association
core   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Special Libraries, April 1931 [PDF]

open access: yes, 1930
Volume 22, Issue 4https://scholarworks.sjsu.edu/sla_sl_1931/1003/thumbnail ...
Special Libraries Association
core   +2 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Special Libraries, October 1927 [PDF]

open access: yes, 1927
Volume 18, Issue 8https://scholarworks.sjsu.edu/sla_sl_1927/1007/thumbnail ...
Special Libraries Association
core   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Special Libraries, December 1962 [PDF]

open access: yes, 1962
Volume 53, Issue 10https://scholarworks.sjsu.edu/sla_sl_1962/1009/thumbnail ...
Special Libraries Association
core   +5 more sources

Special Libraries, January 1928 [PDF]

open access: yes, 1928
Volume 19, Issue 1https://scholarworks.sjsu.edu/sla_sl_1928/1000/thumbnail ...
Special Libraries Association
core   +1 more source

Home - About - Disclaimer - Privacy